Literature DB >> 23408848

Tuberculosis relapse in Vietnam is significantly associated with Mycobacterium tuberculosis Beijing genotype infections.

Mai N T Huyen1, Tran N Buu, Edine Tiemersma, Nguyen T N Lan, Nguyen H Dung, Kristin Kremer, Dick V Soolingen, Frank G J Cobelens.   

Abstract

BACKGROUND: In Vietnam, the Mycobacterium tuberculosis Beijing genotype is associated with multi-drug resistance and is emerging. A possible explanation for this genotype's success is an increased rate of relapse.
METHODS: In a prospective cohort study, isolates from patients with smear-positive tuberculosis were subjected to drug susceptibility testing and to spoligotyping and variable number of tandem repeats typing before treatment and after recurrence of tuberculosis.
RESULTS: Among 1068 patients who were actively followed up over 18 months for recurrence, 23 relapse cases occurred (1.39 cases/100 person-years). After adjustment for genotype, tuberculosis treatment history, and drug resistance, relapse was significantly associated with the Beijing genotype (adjusted hazard ratio [aHR], 5.48; 95% confidence interval [CI], 2.06-14.55) and isoniazid resistance (aHR, 5.91; 95% CI, 2.16-16.16).
CONCLUSIONS: The strongly increased relapse rate in tuberculosis cases caused by Beijing strains probably contributes to the successful spread of this genotype in Vietnam and elsewhere.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23408848     DOI: 10.1093/infdis/jit048

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

1.  Assessment of Bactericidal Drug Activity and Treatment Outcome in a Mouse Tuberculosis Model Using a Clinical Beijing Strain.

Authors:  Bas C Mourik; Gerjo J de Knegt; Annelies Verbon; Johan W Mouton; Hannelore I Bax; Jurriaan E M de Steenwinkel
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

2.  Toll-like Receptor 2 Prevents Neutrophil-Driven Immunopathology during Infection with Mycobacterium tuberculosis by Curtailing CXCL5 Production.

Authors:  Archana Gopalakrishnan; Jillian Dietzold; Sheetal Verma; Madhuri Bhagavathula; Padmini Salgame
Journal:  Infect Immun       Date:  2019-02-21       Impact factor: 3.441

3.  Treatment and recurrence on re-treatment tuberculosis patients: a randomized clinical trial and 7-year perspective cohort study in China.

Authors:  Jian Du; Le Zhang; Yan Ma; X-Y Chen; Q-P Ge; X-Z Tian; Weiwei Gao; Zhongwei Jia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-05       Impact factor: 3.267

4.  Epidemiology of isoniazid resistance mutations and their effect on tuberculosis treatment outcomes.

Authors:  Mai N T Huyen; Frank G J Cobelens; Tran N Buu; Nguyen T N Lan; Nguyen H Dung; Kristin Kremer; Edine W Tiemersma; Dick van Soolingen
Journal:  Antimicrob Agents Chemother       Date:  2013-05-20       Impact factor: 5.191

5.  Associations between human leukocyte antigen class I variants and the Mycobacterium tuberculosis subtypes causing disease.

Authors:  Muneeb Salie; Lize van der Merwe; Marlo Möller; Michelle Daya; Gian D van der Spuy; Paul D van Helden; Maureen P Martin; Xiao-Jiang Gao; Robin M Warren; Mary Carrington; Eileen G Hoal
Journal:  J Infect Dis       Date:  2013-08-14       Impact factor: 5.226

Review 6.  Consequences of genomic diversity in Mycobacterium tuberculosis.

Authors:  Mireia Coscolla; Sebastien Gagneux
Journal:  Semin Immunol       Date:  2014-10-22       Impact factor: 11.130

7.  Recurrence due to relapse or reinfection with Mycobacterium tuberculosis: a whole-genome sequencing approach in a large, population-based cohort with a high HIV infection prevalence and active follow-up.

Authors:  José Afonso Guerra-Assunção; Rein M G J Houben; Amelia C Crampin; Themba Mzembe; Kim Mallard; Francesc Coll; Palwasha Khan; Louis Banda; Arthur Chiwaya; Rui P A Pereira; Ruth McNerney; David Harris; Julian Parkhill; Taane G Clark; Judith R Glynn
Journal:  J Infect Dis       Date:  2014-10-21       Impact factor: 5.226

8.  Discrepancies in Drug Susceptibility Test for Tuberculosis Patients Resulted from the Mixed Infection and the Testing System.

Authors:  Zaoxian Mei; Zhaogang Sun; Dapeng Bai; Yuhui Xu; Zhiling Li; Hairong Huang; Chuanyou Li; Shaofa Xu; Li Li
Journal:  Biomed Res Int       Date:  2015-05-03       Impact factor: 3.411

9.  Mycobacterium tuberculosis Beijing genotype resistance to transient rifampin exposure.

Authors:  Alice L den Hertog; Sandra Menting; Dick van Soolingen; Richard M Anthony
Journal:  Emerg Infect Dis       Date:  2014-11       Impact factor: 6.883

10.  The incidence of recurrence of tuberculosis and its related factors in smear-positive pulmonary tuberculosis patients in Iran: A retrospective cohort study.

Authors:  Mahmood Moosazadeh; Abbas Bahrampour; Mahshid Nasehi; Narges Khanjani
Journal:  Lung India       Date:  2015 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.